| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2871485 | The Annals of Thoracic Surgery | 2016 | 8 Pages |
Abstract
Perioperative mortality and overall survival are significantly associated with the time interval between neoadjuvant chemoradiation and esophagectomy. A “wait and see” approach after neoadjuvant therapy for esophageal adenocarcinoma may not be safe. Further studies based on more detailed data are needed.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jan MD, PhD, George MD, Charles D. MD,